96 related articles for article (PubMed ID: 2476978)
1. Ocular surface keratinization as a predictor of response to topical retinoic acid therapy.
Herbort CP; Weissman SS; Ostler HB; Cevallos A; Char DH
Arch Ophthalmol; 1989 Sep; 107(9):1275-6. PubMed ID: 2476978
[No Abstract] [Full Text] [Related]
2. Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium.
Herbort CP; Zografos L; Zwingli M; Schoeneich M
Graefes Arch Clin Exp Ophthalmol; 1988; 226(1):22-6. PubMed ID: 2449381
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of keratinizing ocular surface disease.
McNamara NA
Optom Vis Sci; 2010 Apr; 87(4):233-8. PubMed ID: 20010137
[TBL] [Abstract][Full Text] [Related]
4. Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease.
Murphy PT; Sivakumaran M; Fahy G; Hutchinson RM
Bone Marrow Transplant; 1996 Sep; 18(3):641-2. PubMed ID: 8879631
[TBL] [Abstract][Full Text] [Related]
5. Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.
Chen Y; Zhang X; Yang L; Li M; Li B; Wang W; Sheng M
Mol Med Rep; 2014 May; 9(5):2015-23. PubMed ID: 24626526
[TBL] [Abstract][Full Text] [Related]
6. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.
Kunert KS; Tisdale AS; Gipson IK
Arch Ophthalmol; 2002 Mar; 120(3):330-7. PubMed ID: 11879137
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
[TBL] [Abstract][Full Text] [Related]
8. Conflict of interest over Harvard drug.
Shulman S
Nature; 1988 Oct; 335(6193):754. PubMed ID: 3185697
[No Abstract] [Full Text] [Related]
9. Secreted Mucins on the Ocular Surface.
Hori Y
Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES151-DES156. PubMed ID: 30481820
[TBL] [Abstract][Full Text] [Related]
10. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
[TBL] [Abstract][Full Text] [Related]
11. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of sialylated epitope recognized by KL-6 monoclonal antibody in ocular surface epithelium of normals and dry eye patients.
Hayashi Y; Kao WW; Kohno N; Nishihara-Hayashi M; Shiraishi A; Uno T; Yamaguchi M; Okamoto S; Maeda M; Ikeda T; Hamada H; Kondo K; Ohashi Y
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2212-7. PubMed ID: 15223797
[TBL] [Abstract][Full Text] [Related]
13. Corneal calcification in dry eye disorders associated with retinoic acid therapy.
Avisar R; Deutsch D; Savir H
Am J Ophthalmol; 1988 Dec; 106(6):753-5. PubMed ID: 3195663
[No Abstract] [Full Text] [Related]
14. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival epithelium expression of HLA-DR in dry eye patients.
Tsubota K; Fujihara T; Saito K; Takeuchi T
Ophthalmologica; 1999; 213(1):16-9. PubMed ID: 9838252
[TBL] [Abstract][Full Text] [Related]
16. The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE.
Soria J; Acera A; Durán JA; Boto-de-Los-Bueis A; Del-Hierro-Zarzuelo A; González N; Reigada R; Suárez T
Exp Eye Res; 2018 Feb; 167():31-43. PubMed ID: 28336260
[TBL] [Abstract][Full Text] [Related]
17. The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes.
Liu X; Wang S; Kao AA; Long Q
Cornea; 2012 Nov; 31(11):1235-9. PubMed ID: 22677643
[TBL] [Abstract][Full Text] [Related]
18. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
[TBL] [Abstract][Full Text] [Related]
19. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye.
Li Z; Woo JM; Chung SW; Kwon MY; Choi JS; Oh HJ; Yoon KC
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):155-62. PubMed ID: 23211823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
